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Abstract 
To investigate the difference between preoperative radiologic tumor size (RTS) and postoperative pathologic tumor 
size (PTS) in patients who underwent nephrectomy for renal cell carcinoma. We retrospectively reviewed 257 patients 
who received preoperative computed tomography (CT) before radical or partial nephrectomy for renal cell carci-
noma from January 2010 to May 2015 in Huashan Hospital, Shanghai. RTS was defined as the largest diameter of 
tumor measured by CT and PTS as the largest diameter of tumor measured in the surgical specimens. Among all 
subjects, mean RTS was larger than PTS (4.57 ± 2.15 vs. 4.02 ± 2.15 cm, P = 0.004) with a discrepancy of 0.55 cm. 
When the patients were categorized according to T stage, the mean RTS was greater than PTS in the following groups: 
≤4 cm group (2.90 vs. 2.59 cm, P = 0.02), >4 and ≤7 cm group (5.08 vs. 4.38 cm, P < 0.0001), except for >7 cm (8.9 
vs. 8.0 cm, P = 0.142). Among patients with clear cell RCC, the mean RTS was larger than the mean PTS (4.57 vs. 
3.98 cm, P = 0.004), similar result was also seen in non-clear cell group (4.54 vs. 4.16 cm, P = 0.045). The mean RTS 
was larger than PTS for the approach of radical nephrectomy (RN) (5.26 vs. 4.64 cm, P = 0.01), but not for the partial 
nephrectomy (PN) (3.34 vs. 2.92 cm, P = 0.067). Of the 257 renal cancers, 76 tumors were down-staged when compar-
ing radiographic and pathologic tumor maximal diameter. The proportion of down-staged tumors had no differ-
ence between different genders (P = 0.283), different surgery approaches (P = 0.102), and different pathology types 
(P = 0.209). In this study, we found that renal tumor size was overestimated by radiography compared with patho-
logic results, and the T staging of some tumors was down-staged. But for patients who underwent PN, there was no 
difference between RTS and PTS. These results suggested that the PN should be considered first for the T1b renal 
tumor when tumor size was close to 4 cm, while the recommendation level of PN for T1b tumor was grade B accord-
ing to EAU guidelines.
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Background
Renal cell cancer (RCC) represents 2–3  % of all can-
cers. The estimated new cases and deaths were 61,560 
and 14,080 in US in 2015 (Siegel et al. 2015). Despite the 
rapid increase for several decades, the incidence rates of 
RCC stabilized during the year of 2007 and 2011. It may 
partially attribute to the increasing use of abdominal 
imaging test in annual heath examination. In addition, 
the death rates decreased by 0.9 % per year from 2007 to 
2011 (American Cancer Society 2015). Nevertheless, due 
to the relatively high incidence, RCC had became one of 
the most important healthcare issues worldwide.
For the localised RCC, surgery is the only curative 
treatment with high-quality evidence. Partial nephrec-
tomy (PN) and radical nephrectomy (RN) are the two 
major styles of surgical procedures. And the size of a 
renal tumor is important for staging, prognosis and the 
selection of the appropriate surgical procedure. For local-
ized tumor, of which the T staging is T1, PN is recom-
mended by guidelines (Motzer et  al. 2015; Ljungberg 
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et  al. 2015). The decision of performing PN is normally 
determined by the radiologic size, but not the pathologic 
size. The radiologic size of tumor is usually measured by 
preoperative CT scan (Satasivam et al. 2012). Therefore, 
it is necessary to investigate the difference between path-
ologic and radiologic sizes, which would help urologists 
to make better decisions in clinical practice.
Some studies have revealed that there existed a certain 
degree of discrepancy between the preoperative size of 
renal tumors as measured by CT and the pathologic size 
as determined from surgical specimens (Choi et  al. 2015; 
Chen et al. 2013; Lee et al. 2010). Since a discrepancy often 
exists between the preoperative radiologic tumor size (RTS) 
and the postoperative pathologic tumor size (PTS), the 
over-estimated tumor size by CT might cause the upstage 
of preoperative T stage and lead to the loss of opportunity 
to receive PN for quite a number of the patients (Kanofsky 
et  al. 2006; Aertsen et  al. 2013). Thus we performed this 
study to evaluate whether the discrepancies between the 
radiologic and pathologic sizes have an impact on tumor 
staging and the appropriate choice of surgical procedure.
Results
In current study, a total of 257 patients were included, 
among which 181 were men (70.4 %) and 76 were women 
(29.6  %). The baseline characteristics of the patients 
were shown in Table  1. The median age was 56.8  years 
(range 18–86  years) and the median BMI was 24.46 
(range 15.63–32.37). Among these subjects, 164 (63.8 %) 
received RN and 96 (36.2 %) underwent PN. Among all 
the patients, there were 183 patients (71.2  %) with T1a 
clinical stage and 57 (22.2 %) with T1b clinical stage. The 
most common histologic subtype was clear cell (80.9 %). 
All tumors had no positive margins.
The mean RTS were larger than PTS (4.57 ±  2.15 vs. 
4.02 ± 2.15 cm, P = 0.004) with a discrepancy of 0.55 cm. 
In addition, when the RTS was ≤4  cm, the mean RTS 
(2.90 cm) was still larger than PTS (2.59 cm) (P = 0.002) 
and such difference also existed when the RTS was 
4–7 cm (RTS 5.08 cm vs. PTS 4.38 cm, P < 0.0001). How-
ever, when the RTS was > 7 cm, the mean RTS (8.9 cm) 
and mean PTS (8.0  cm) were not statistically different 
(P = 0.142) (Table 2).
Table 1 Demography
Feature Median ± SD or n (%) RTS (cm) PTS (cm) P value
No. of total subjects 257
Age (years) 56.8 (range 18–86)
Gender
 Male 181 (70.4 %) 4.41 ± 1.96 3.84 ± 1.85 <0.0001
 Female 76 (29.6 %) 4.93 ± 2.54 4.43 ± 2.72 <0.0001
BMI 24.46 (range 15.63–32.37)
Tumor side
 Left 117 (45.5 %) 4.70 ± 2.25 4.16 ± 2.28 <0.0001
 Right 140 (54.5 %) 4.46 ± 2.07 3.90 ± 2.04 <0.0001
Surgery type
 RN 164 (63.8 %) 5.26 ± 2.12 4.64 ± 2.21 0.01
 PN 93 (36.2 %) 3.34 ± 1.60 2.92 ± 1.54 0.067
Histology
 Clear cell 208 (80.9 %) 4.57 ± 2.09 3.98 ± 2.06 0.004
 Chromophobe 9 (3.5 %) 4.54 ± 2.42 4.16 ± 2.51 0.045
 Papillary 11 (4.3 %)
 Collecting duct 1 (0.4 %)
 Adenocarcinoma 2 (0.8 %)
 ccRCC + adenocarcinoma 5 (1.9 %)
 Other 21 (8.2 %)
Pathologic T stage
 T1a 183 (71.2 %) 3.67 ± 1.25 3.04 ± 0.97 <0.0001
 T1b 57 (22.2 %) 5.87 ± 1.31 5.37 ± 0.87 0.001
 T2a 11 (4.3 %)
 T2b 6 (2.3 %)
RTS (cm) 4.57 ± 2.15 0.004
PTS (cm) 4.02 ± 2.15
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In subgroup analysis, among patients with clear cell 
RCC, the mean RTS was larger than the mean PTS (4.57 
vs. 3.98 cm, P = 0.004), and same for the non-clear cell 
group (4.54 vs. 4.16 cm, P = 0.045). The mean RTS was 
significantly larger than PTS (5.26 vs. 4.64 cm, P = 0.01) 
for the approach of RN, but not for the approach of PN 
(3.34 vs. 2.92 cm, P = 0.067).
Of the 257 renal cancers, 76 tumors were down-staged 
when comparing radiographic and pathologic tumor 
maximal diameter including 62 T1b  →  T1a (21.4  %) 
and 14 T2a → T1b (8.2 %). And there was significantly 
difference (P  <  0.0001) between RTS and PTS When 
the patients were categorized by down-staged tumors 
(Table  3). Besides, there was no difference of down-
staged tumor proportion (P = 0.283) between male and 
female, PN and RN (P  =  0.102), or ccRCC and non-
ccRCC (P = 0.209). 
Discussion
In this study, we found that radiologically measured size 
of renal mass was overestimated compared with patho-
logic size as previously reported by others. And there 
was statistically difference between RTS and PTS for 
different tumor side and gender. Besides, the T staging 
of some tumors was down-staged. However, observed 
discrepancy between the preoperative size of renal 
tumors as measured by CT and the pathologic size as 
determined from surgical specimens was minimal, usu-
ally less than 1  cm, which was statistically insignificant. 
And for the result of PN procedure, there was no differ-
ence between RTS and PTS. According to our results, we 
thought that CT generally provided an accurate assess-
ment of the actual size of renal tumors. We considered 
that PN should be considered first for the T1b tumor 
when its size was close to 4 cm, while the recommenda-
tion for PN of T1b was grade B according to EAU guide-
lines. Although the difference between RTS and PTS was 
statistically significant, we do not think this disparity rep-
resents a clinically significant result.
PN surgery is recommended (Grade A) in patients 
with T1a tumors according to EAU guideline (Ljung-
berg et  al. 2015). But more recent researches suggested 
that a threshold of >4 cm and even 7 cm for appropriately 
selected patients was safe and effective (Roos et al. 2011; 
Becker et al. 2011). In our study, the tumors with radio-
graphic size close to 4 cm were overestimated by CT, and 
such discrepancy might affect the choice between RN 
and PN. However, the situation is different if the size of 
the tumor was larger than 4 cm. In some centers, a tumor 
size of 4 cm is still regarded as the cutoff between RN and 
PN. Recent studies have shown that PN for renal tumors 
had superior intermediate-term preservation of renal 
function, and similar recurrence rate compared with RN 
(Favaretto et al. 2013; Lane et al. 2010). Our results sug-
gested that the PN should be considered first for the T1b 
tumor whose size was close to 4 cm, namely the thresh-
old of tumor size of 4 cm for PN should been expanded 
to some extent.
A reduction in renal tumor size is commonly observed 
after surgical resection because of a loss of blood in the 
tumor. This tumor size reduction has an impact on the final 
pathologic stage in organ-confined tumors for which size is 
the only criterion. There were still some limitations in the 
current study. (1), this study was retrospective, and patients 
were from a single institution, which might result in the 
bias commonly seen in such kind of studies. (2), the sample 
size was relatively small, and we needed more cases to vali-
date our results (3), a sub-analysis was not performed for 
non-clear cell histology due to the relatively small number 
of cases, and the data of Fuhrman grading was lacking.
Conclusions
In this study, we found that renal tumor size was overesti-
mated by radiography compared with pathologic results, 
and the T staging of some tumors was down-staged. But 
for patients who underwent PN, there was no difference 
between RTS and PTS. These results suggested that the 
PN should be considered first for the T1b renal tumor 
when tumor size was close to 4 cm, while the recommen-
dation level of PN for T1b tumor was grade B according 
to EAU guidelines.
Methods
The records of 257 patients from Huashan Hospital, 
Shanghai, who underwent PN or RN for renal tumors 
from January 2010 to May 2015 were retrospectively 
reviewed upon receiving the approval from our institu-
tional review board. All the patients were undergoing 
preoperative CT scans at our institution within 4 weeks 
before surgery. RTS was defined as the largest diameter 
Table 2 The mean RTS and PTS by RTS and clinical stage
T-stage RS range N RTS (cm) PTS (cm) P value
T1a ≤4 cm 115 (44.7 %) 2.90 ± 0.73 2.59 ± 0.76 0.002
T1b >4, ≤7 cm 111 (43.2 %) 5.08 ± 0.82 4.38 ± 1.19 <0.0001
T2 >7 cm 31 (12.1 %) 8.9 ± 0.73 8.0 ± 2.73 0.142
Total 257 4.57 ± 2.15 4.02 ± 2.15 0.004
Table 3 The mean RTS and PTS by down-staged tumors
Down-staged 
tumors
N RTS (cm) PTS (cm) P value
T1b → T1a 62 (21.4 %) 4.74 ± 0.64 3.60 ± 0.50 <0.0001
T2a → T1b 14 (8.2 %) 7.54 ± 0.33 6.00 ± 0.81 <0.0001
No change 181 (70.4 %) 4.28 ± 2.38 4.01 ± 2.47 <0.0001
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of tumor measured by CT images and PTS was defined 
as the largest diameter of tumor measured in the surgical 
specimen. We compared and analyzed the two param-
eters. Other clinical information, including patients’ age, 
gender, body mass index (BMI), histologic subtype of 
tumor, tumor side, tumor T staging, and type of surgery 
received, were also assessed. The tumors were staged 
radiologically and pathologically using the 2010 TNM 
staging system as follows: T1a, less than 4 cm; T1b, 4 cm 
or more but less than 7  cm; and T2, larger than 7  cm. 
Downstaging of tumors was determined by comparing 
the radiologic stage with the pathologic stage.
In our analysis, patients were categorized according 
to patients’ age, gender, histologic subtype, tumor side, 
T staging, operating approach and down-staged tumors. 
Mean values of radiological and pathologic tumor size 
along with differences in radiographic and pathologic 
tumor sizes were calculated for each category. The SPSS 
software package version 11.0 (Statistical Package for 
Social Sciences, Chicago, IL, USA) was used for statisti-
cal analysis. Data for Continuous variables were shown 
as median ± standard deviation and compared using the 
Student’s t test. Categorical variables were shown as per-
centage and compared using Pearson’s Chi square test. 
The comparison between tumor sizes was performed 
using the paired t test. A P value of <0.05 was considered 
to be statistically significant.
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